Personal profile
Research interests
As a PhD candidate i am participating in the BRVO and BRDME studies: two randomized, controlled, double masked, clinical trials. Both studies compare the effectiveness and costs of bevacizumab to ranibizumab in patients with retinal veins occlusions and diabetic macular edema respectively. It is hypothisized that bevacizumab is non-inferior to ranibizumab regarding effectiveness in both studies.
Besides the clinical outcomes, we will analyse blood plasma from included patients to look for potential biomarkers. We will evaluate the diagnostic value of individual or combinations of selected candidate biomarkers of diabetic retinopathy. Finding reliable biomarkers for diabetic retinopathy would facilitate early diagnoses and therefore early treatment.
Specialisation
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Research output
- 1 Article
-
Mirna levels as a biomarker for anti-vegf response in patients with diabetic macular edema
Vader, M. J. C., Habani, Y. I., Schlingemann, R. O., Klaassen, I. & Vader, M. J. C., 1 Dec 2021, In: Journal of Personalized Medicine. 11, 12, 1297.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile26 Downloads (Pure)